Seminários 1, 2 e 3 (09/04/2021 - 09/04/2021)
# Seminário 1 – LL-00066471, a novel positive allosteric modulator of α7 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: discovery and preclinical characterization (https://doi.org/10.1016/j.ejphar.2020.173685).
# Seminário 2 – Ameliorative effect of deoxyvasicine on scopolamine-induced cognitive dysfunction by restoration of cholinergic function in mice (https://doi.org/10.1016/j.phymed.2019.153007).
#Seminário 3 - Does cholinergic stimulation affect the P2x7 receptor-mediated dye uptake in mast cells and macrophages? (Frontiers in Cellular Neuroscience. www.frontiersin.org, v 14 | Article 548376.